MEDS
DataMEDS AI, Inc.
Healthcare — Medical Distribution
DataMEDS AI, Inc. operates as a health IT company in the United States. The company focuses on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units to deliver an enhanced healthcare experience for consumers. It offers tools, such as the EinsteinRx, a pharmacy dispensing AI platform; the PharmacyChain, a smart contracts platform; Patient Rx Adherence Tool; and HubRx AI. It also operates as a pharmacy distributor; and provides clinical concierge services, . The company was formerly known as Wellgistics Health, Inc. and changed its name to DataMEDS AI, Inc. in July 2026. DataMEDS AI, Inc. was incorporated in 2022 and is based in Tampa, Florida.
Price History
Fundamentals
| Market Cap | $8.60M |
| P/E Ratio (TTM) | - |
| Forward P/E | - |
| EPS (TTM) | $-44.00 |
| Dividend Yield | - |
| Profit Margin | - |
| Revenue Growth | -85.60% |
| ROE | - |
| Debt/Equity | - |
| Recommendation | None |
| Analyst Target | - |
| Analysts | - |
| Next Earnings | - |
| Indexes | - |
Technical Indicators
| RSI (14) | 51.9 |
| Beta | - |
| SMA 20 | $3.06 |
| SMA 40 | $3.25 |
| 52-Week High | $97.50 |
| 52-Week Low | $2.49 |
| 50-Day Avg | $3.45 |
| 200-Day Avg | $13.82 |
| Avg Volume | 556.1K |
| Volume | 44.7K |
Performance Analysis
NEUTRALMEDS presents a mixed picture with both positive and negative indicators.
Recent News
Last updated: Aug 01, 2026 04:15 UTC
Back to Screener Export Report